Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Baloxavir marboxil is a prodrug of baloxavir acid, an endonuclease inhibitor developed for influenza treatment. Its core synthesis involves esterification to enhance oral bioavailability. <strong>Molecular Formula</strong>: C26H19F3N4O7S; <strong>CAS No.</strong>: 1589302-57-3.</p>
<h3>Application</h3>
<ul>
<li><strong>Viral Therapy</strong>: Targeted treatment for uncomplicated influenza A and B in high-risk patients.</li>
<li><strong>Prophylaxis</strong>: Post-exposure prevention in household contacts during outbreaks.</li>
<li><strong>R&D</strong>: Reference standard for antiviral efficacy studies in pharmaceutical laboratories.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe hepatic impairment. Store below 25°C in dry, light-resistant conditions. Clinical use requires monitoring for viral resistance mutations.</p>